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Abstract
Background: There are few and debated data regarding possible differences in the clinical presentations of
influenza A/H1N1, A/H3N2 and B viruses in children. This study evaluates the clinical presentation and socio-
economic impact of laboratory-confirmed influenza A/H1N1, A/H3N2 or B infection in children attending an
Emergency Room because of influenza-like illness.
Methods: Among the 4,726 children involved, 662 had influenza A (143 A/H1N1 and 519 A/H3N2) and 239
influenza B infection detected by means of real-time polymerase chain reaction. Upon enrolment, systematic
recordings were made of the patients’ demographic characteristics and medical history using standardised written
questionnaires. The medical history of the children was re-evaluated 5-7 days after enrolment and until the
resolution of their illness by means of interviews and a clinical examination by trained investigators using
standardised questionnaires. During this evaluation, information was also obtained regarding illnesses and related
morbidity among households.
Results: Children infected with influenza A/H1N1 were significantly younger (mean age, 2.3 yrs) than children
infected with influenza A/H3N2 (mean age, 4.7 yrs; p < 0.05)) or with influenza B (mean age, 5.2 yrs; p < 0.05).
Adjusted for age and sex, children with influenza A/H3N2 in comparison with those infected by either A/H1N1 or
with B influenza virus were more frequently affected by fever (p < 0.05) and lower respiratory tract involvement (p
< 0.05), showed a worse clinical outcome (p < 0.05), required greater drug use (p < 0.05), and suffered a worse
socio-economic impact (p < 0.05). Adjusted for age and sex, children with influenza B in comparison with those
infected by A/H1N1 influenza virus had significantly higher hospitalization rates (p < 0.05), the households with a
disease similar to that of the infected child (p < 0.05) and the need for additional household medical visits (p <
0.05).
Conclusions: Disease due to influenza A/H3N2 viral subtype is significantly more severe than that due to influenza
A/H1N1 subtype and influenza B virus, which indicates that the characteristics of the different viral types and
subtypes should be adequately considered by health authorities when planning preventive and therapeutic
measures.
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Background
A number of recent surveys of the total burden of pediatric
seasonal influenza [1-4] have demonstrated that, although
generally more dangerous in children at risk of influenza-
related complications because of chronic underlying disease,
it is also very common in otherwise healthy children, a con-
siderable number of whom experience severe disease lead-
ing to excess hospitalisation rates, increased outpatient
visits and antibiotic prescriptions, and (although rarely)
even death [5]. Moreover, as children are particularly
responsible for the spread of influenza, their disease has
substantial socio-economic consequences because of the
high rate of transmission among family members [3,6].
Among the influenza viruses causing disease in humans,
types A and B are the most frequently isolated [7]. Despite
all of them can infect subjects of all ages, community-
based surveillance systems have found that A/H3N2 influ-
enza virus is more frequently isolated in adults (including
elderlies), influenza A/H1N1in young children and influ-
enza B in school-age children [8]. However, there are few
and debated data regarding possible differences in the clin-
ical presentations of influenza A and B viruses in children.
Some studies found a similar constellation of clinical signs
and symptoms [9,10], whereas others indicate that influ-
enza B infection may be more frequently associated with
encephalitis, fatal pneumonia and myositis [11-13]. On the
other hand, an ill appearance and more severe signs and
symptoms of disease leading to higher hospitalisation rates
are considered to be more common in children infected
with influenza A [14-16].
Among the influenza A viruses, the H1N1 and H3N2
subtypes are the most common causes of disease [7,9],
but little is known about their relative importance in
determining the clinical features of the disease in pedia-
trics. Because the use of extensive vaccination against
influenza among healthy children is not recommended
in most industrialised countries [17,18], more data are
needed to define whether the different subtypes may be
risk factors for severe disease and hospitalisation.
Furthermore, an awareness of the different clinical man-
ifestations relating to viral subtype is particularly neces-
sary when antiviral agents are used because the
resistance of viral strains seems to be different [19,20].
This paper describes the clinical presentation and
socio-economic impact of laboratory-confirmed influ-
enza A (H1N1 and H3N2) or B infection in 901 other-
wise healthy children attending an Emergency Room
(ER) because of influenza-like illness during the influ-
enza seasons 2007-2008 and 2008-2009.
Methods
Study design
This multicentre prospective study was carried out dur-
ing the winters of 2007-2008 and 2008-2009 (from 1
November to 31 March) in the ERs of five children’s
hospitals in Italy (Milan, Padua, Genoa, Naples and
Bari). The study protocol was approved by the Institu-
tional Review Board of each participating centre; the
written informed consent of a parent or legal guardian
was required, and the older children were asked for
their assent.
Study population
The study enrolled subjects aged less than 15 years and
without any underlying severe chronic disease who
attended an ER because of an influenza-like illness as
defined by the Italian Ministry of Health (http://www.
ministerosalute.it) [21,22]. According to this definition,
influenza-like disease was considered as an acute
respiratory disease: of sudden onset; with fever (a tem-
perature of > 38°C); accompanied by at least one of the
following general symptoms: headache, generalised
malaise, a feverish sensation (sweating and chills), asthe-
nia; accompanied by at least one of the following
respiratory symptoms: cough, pharyngodynia, nasal
congestion.
The exclusion criteria were chronic diseases increasing
the risk of complications of viral respiratory infections,
including premature birth; chronic disorders of the pul-
monary or cardiovascular systems including asthma;
chronic metabolic diseases, including diabetes mellitus;
neoplasia; kidney or liver dysfunction; hemoglobinopa-
thies; immunosuppression; diseases requiring long-term
aspirin therapy; and genetic or neurological disorders.
Moreover, also those children whose parents could not
assure the follow-up according to the study design were
excluded. Because the study protocol did not include
any invasive procedure and due to its epidemiologic nat-
ure, there was almost complete participation of the par-
ents in the study.
During winter 2007-2008, the patients were enrolled
two days per week (Wednesday and Sunday); during
winter 2008-2009, they were enrolled every day. Upon
enrolment in both seasons, systematic recordings were
made of the patients’ demographic characteristics and
medical history using standardised written question-
naires [21,22]. The questions covered the signs and
symptoms of the acute disease, laboratory and/or radi-
ological examinations, prescribed drug therapy, the pre-
vious administration of influenza vaccine, family size
and the number of siblings, the parents’ education and
occupation, the family’s living conditions, and informa-
tion concerning child care attendance. After a complete
clinical examination, the study patients were classified
into disease groups on the basis of signs and/or symp-
toms using well-established criteria [23]. In the case of
signs and symptoms of more than one disease, the chil-
dren were entered in the more severe disease group.
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Acute otitis media was diagnosed using pneumatic oto-
scopy [23] and community-acquired pneumonia by
means of chest radiography [23].
A nasopharyngeal sample was collected from all of the
children using a pernasal flocked swab, which was
stored in a tube containing 1 mL of UTM-RT (Kit Cat.
No. 360c, Copan Italia, Brescia, Italy).
The medical history of the children was re-evaluated
5-7 days after enrolment and every two days until the
resolution of their illness by means of interviews and a
clinical examination (in the outpatient clinic if they
were discharged or in the ward if they were hospitalized)
by trained investigators using standardised question-
naires [11,12]. During this evaluation, information was
also obtained regarding illnesses and related morbidity
among households. The patients’ parents or legal guar-
dians were asked to answer a list of questions regarding
the outcome of the disease in their children and the
involvement of other family members. All of the data of
the study children and their households were verified
from medical records.
Laboratory assays
Each sample underwent real-time polymerase chain
reaction (PCR) in order to identify A and B influenza
viruses as previously described [24,25]. Viral RNA for
subtyping was extracted from 150 μL of swab transport
medium using a QIAxtractor, a VX reagent kit and a
virus protocol (Qiagen, Crawley, UK). Reverse transcrip-
tion plates were then set up using a Qiagility robot
(Qiagen): 40 μL reactions were performed using 200 U
MMLV reverse transcriptase (Invitrogen, Paisley, UK),
16 U rRNas in RNase inhibitor (Promega, Southampton,
UK), 0.2 μg random hexamers (Thermo Scientific, West
Sussex, UK), 0.4 mM of each dNTP, 7.5 mM MgCl2,
and 1x Taq DNA Polymerase PCR Buffer (Invitrogen).
The plates were incubated at room temperature for 10
minutes, then at 37°C for 45 minutes, and finally at 95°
C for five minutes. Multiplex real-time PCR was per-
formed using a Taqman Fast Universal PCR Master Mix
(Applied Biosystems, Warrington, UK), fast cycling con-
ditions, and the following primer-probes on an ABI
7500 Fast instrument (Applied Biosystems) (final con-
centrations in parentheses): A/H1-forward GGAA-
TAGCCCCCCTACAATTG (1 μM); A/H1-reverse
AATTCGCATTCTGGGTTTCCTA (1 μM); A/H1
probe NED-CGTTGCCGGATGGA-MGBNFQ (0.05
μM); A/H3-forward CCTTTTTGTTGAACGCAGCAA
(1 μM); A/H3-reverse CGGATGAGGCAACTAGT-
GACCTA (1 μM); A/H3-probe VIC-CCTACAG-
CAACTGTTACC-MGBNFQ (0.25 μM); B-forward
TCACGAAAAATACGGTGGATTAAA (0.75 μM); B-
reverse TTTGGTTCCATTGGCMAGCT (0.75 μM); B-
probe 6FAM-CCAATATGGGTGAAAAC-MGBNFQ
(0.3 μM). The influenza A (including subtypes) and B
RNA was relatively quantified; the criterion for a posi-
tive reaction was a cycle threshold (CT) of < 40 cycles.
Statistical analysis
The data were analysed using SAS for Windows v. 9.1
(SAS Institute, Cary, NC, USA), and comparisons were
made between the different viral types and subtypes.
The continuous variables are presented as mean values
± standard deviation (SD) or median values with range,
and the categorical variables as numbers and percen-
tages. The continuous data were analysed using a two-
sided Student’s t-test after checking their normal distri-
bution (based on the Shapiro-Wilk statistic) or a two-
sided Wilcoxon’s rank-sum test otherwise. The categori-
cal data were analysed using contingency table analysis
with the chi-squared or Fisher’s test as appropriate. The
multivariate odds ratios (OR) of the influenza virus sub-
types (influenza A/H1N1, influenza A/H3N2, or influ-
enza B), and the corresponding 95% confidence intervals
(CI) were calculated using unconditional multiple logis-
tic regression models, including terms for age and
gender.
Results
The study involved a total of 4,726 children (2,599
males; mean age ± SD, 3.34 ± 3.06 years): 1,170 (24.8%)
during winter 2007-2008 and 3,556 (75.2%) during win-
ter 2008-2009. Influenza A viruses were detected in 729
(15.4%): 164/1,170 (14.0%) in the first year and 565/
3,556 (15.9%) in the second; influenza B viruses were
detected in 239 (5.1%), 179/1,170 (15.3%) in 2007-2008
and 60/3,556 (1.7%; p < 0.0001) in 2008-2009. Despite
the differences in prevalence during the two seasons, all
the viral types co-circulated during 2007-2008 and
2008-2009, and no co-infection between different influ-
enza types was observed. The influenza A viruses were
subtyped in 150 of the 164 samples collected in the first
year (91.5%) and 512 of the 565 samples collected in the
second year (90.6%): subtype A/H1N1 was identified in
respectively 126/150 (84%) and 17/512 cases (3.3%; p <
0.0001), and subtype A/H3N2 in 24/150 (16%) and 495/
512 (96.7%; p < 0.0001). There was no between-centre
difference in the prevalence of the different viral types
or subtypes. As a preliminary evaluation showed that
the demographic characteristics, clinical presentations,
clinical outcomes and socio-economic impact were simi-
lar in the two seasons, the patients were considered
together on the basis of the detected viral type and sub-
type. Consequently, the analysis was based on 662 chil-
dren with influenza A (143 A/H1N1 and 519 A/H3N2)
and 239 with influenza B.
Table 1 shows the demographic and clinical data of
the enrolled children by the infecting influenza viral
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type and subtype. In comparison with the children with
the A/H3N2 subtype, those with the A/H1N1 subtype
were significantly younger (p < 0.05), experienced fever
less frequently (including high grade fever) (p < 0.05),
and were significantly less frequently affected by lower
respiratory tract infections (p < 0.05) and fever without
source (p < 0.05) upon enrolment. Wheezing and pneu-
monia were significantly more frequent among the
patients infected with the A/H3N2 subtype (p < 0.05).
With the exception of mean age as well as age distribu-
tion (p < 0.05) and the prevalence of acute bronchitis (p
< 0.05) and myositis (p < 0.05), the demographic and
clinical data of the patients with the A/H1N1 subtype
were similar to those of the influenza B-positive
children.
Table 2 summarises clinical outcomes and drug use.
In comparison with the children infected by the A/
H3N2 subtype, those infected by A/H1N1 had a signifi-
cantly lower hospitalisation rate (p < 0.05), a signifi-
cantly shorter duration of hospitalisation (p < 0.05) and
absence from school (p < 0.05), and made significantly
less frequent use of antibiotics (p < 0.05), antipyretics (p
< 0.05), aerosol therapy (p < 0.05) and steroids (p <
0.05). However, although the hospitalisation rate was
significantly lower among the children infected by the
A/H1N1 subtype than in those infected by influenza B
(p < 0.05), the clinical outcomes and drug use were
similar in these two groups.
Table 3 shows the socio-economic impact of the
influenza viral types and subtypes on the household
contacts of the study children. The household impact
of the A/H1N1 subtype was quite different from that
of the A/H3N2 subtype. The prevalence of disease
similar to that of the infected children (p < 0.05), the
number of medical visits (p < 0.05), the number of
antibiotic prescriptions (p < 0.05), the number of
working days lost by mothers (p < 0.05) and fathers (p
< 0.05), and the number of school days lost by siblings
(p < 0.05) were significantly lower in the case of the
A/H1N1 subtype. The socio-economic impact of the
A/H1N1 subtype was also significantly lower than that
due to influenza B virus for the majority of the studied
variables (p < 0.05).
Table 4 shows the multivariate ORs of the influenza
virus subtypes and their 95% CIs on the basis of the
characteristics of the study patients and their








Males 79 (55.2) 312 (60.1) 125 (52.3)
Mean age ± SD, yrs 2.33 ± 1.40*° 4.69 ± 3.07 5.17 ± 3.21
Age groups, No. (%)
< 2 yrs 39 (27.3)* 22 (4.2) 76 (31.8)*
2-5 yrs 103 (72.0)*° 491 (94.6) 74 (30.9)*
> 5 yrs 1 (0.7)° 6 (1.2) 89 (37.2)*
Presence of fever” (%) 109 (76.2)* 452 (87.1) 179 (74.8)*
High-grade fever° (%) 106 (74.1)* 416 (80.2) 169 (70.7)*
Respiratory tract infection (%) 128 (89.5) 436 (84.0) 205 (85.8)
Upper respiratory tract
Infection (%)
107 (61.5)* 261 (50.3) 164 (68.7)*
Common cold (%) 69 (48.3)* 56 (10.8) 92 (38.5)*
Pharyngitis (%) 33 (23.1) 140 (26.9) 54 (22.5)
Acute otitis media (%) 9 (6.3) 46 (8.9) 14 (5.9)
Croup (%) 4 (2.8) 11 (2.1) 4 (1.7)
Lower respiratory tract
infection (%)
21 (14.6)* 175 (33.7) 41 (17.2)*
Acute bronchitis (%) 24 (16.8)° 83 (15.9) 21 (8.8)*
Wheezing (%) 3 (2.0)* 58 (11.1) 7 (2.9)*
Pneumonia (%) 0 (0.0)* 34 (6.5) 13 (5.4)
Gastroenteritis (%) 5 (3.5) 17 (3.3) 11 (4.6)
Fever without source (%) 6 (4.2)* 52 (10.0) 7 (2.9)*
Febrile seizures (%) 4 (2.7) 14 (2.7) 4 (1.7)
Myositis (%) 0 (0.0)° 0 (0.0) 12 (5.0)
“Defined as an axillary temperature of ≥37.6°C or a rectal temperature of ≥38°C; °defined as an axillary temperature of ≥39°C or a rectal temperature of ≥39.5°C.
SD, standard deviation. °p < 0.05 vs influenza B; *p < 0.05 vs A/H3N2; no other statistically significant differences.
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households. All the variables mentioned in the preced-
ing Tables were evaluated, but only those who showed
significant differences between different set of viruses
upon adjustment for age and sex are reported.
Adjusted for age and sex, children with influenza A/
H3N2 in comparison with either A/H1N1 or with B
virus infection showed significantly more often fever
(including high-grade fever) (p < 0.05), lower respira-
tory tract involvement (p < 0.05), fever without source
(p < 0.05), need of hospitalization (p < 0.05), absence
from school (p < 0.05), requirement of antibiotics (p <
0.05) and antipyretics (p < 0.05) as well as aerosol
therapy (p < 0.05) and steroids (p < 0.05), the house-
holds with a disease similar to that of the infected
child (p < 0.05), the need for additional household
medical visits (p < 0.05) and antibiotic prescriptions (p
< 0.05), a longer period of lost work days by parents (p
< 0.05) and school days by siblings (p < 0.05). Adjusted
for age and sex, children with influenza B in compari-
son with those infected by A/H1N1 influenza virus had
significantly higher hospitalization rates (p < 0.05), the
households with a disease similar to that of the
infected child (p < 0.05) and the need for additional
household medical visits (p < 0.05).
Table 2 Clinical outcome and drug use among the study population by viral type and subtype
Data Viral findings
Influenza A/H1N1 (n = 143) Influenza A/H3N2 (n = 519) Influenza B (n = 239)
Clinical outcome
Hospitalisation rate, No.(%) 6 (4.2)*° 87 (16.8) 30 (12.5)
Duration of hospitalisation,
mean days ± SD
5.2 ± 3.4* 7.6 ± 4.4 4.6 ± 2.6*
Absence from school,
mean days ± SD
6.10 ± 4.93* 7.61 ± 4.44 6.43 ± 5.01*
Drug use, No. (%)
Antibiotics (%) 109 (76.2)* 470 (90.5) 179 (74.9)*
Antipyretics (%) 113 (79.0)* 469 (90.3) 190 (79.5)*
Aerosol therapy (%) 36 (25.2)* 222 (42.8) 63 (26.3)*
Steroids (%) 6 (4.2)* 57 (10.9) 8 (3.3)*
SD, standard deviation. °p < 0.05 vs influenza B; *p < 0.05 vs A/H3N2; no other statistically significant differences.
Table 3 Socioeconomic impact of influenza viruses on household contacts of the study children by viral type and
subtype.
Viral findings
Data Households of Influenza A/H1N1-
positive children (n = 363)
Households of Influenza A/H3N2-
positive children (n = 1,296)
Households ofB-positive
children (n = 597)
Disease similar to that of the
infected child (%)
70/363 (19.3)*° 417/1,296 (32.2) 159/597 (26.6)*
Mothers, No. (%) 16/143 (11.2)*° 173/519 (33.3) 58/239 (24.3)*
Fathers, No. (%) 18/139 (12.9)* 103/519 (19.8) 37/239 (15.5)
Siblings, No. (%) 36/81 (44.4)*° 141/258 (54.7) 64/119 (53.8)
Additional medical visits (%) 45/363 (12.4)*° 325/1,296 (25.1) 125/597 (20.9)*
Mothers, No. (%) 12/143 (8.4)*° 134/519 (25.8) 46/239 (19.2)*
Fathers, No. (%) 6/139 (4.3)*° 55/519 (10.6) 21/239 (8.8)
Siblings, No. (%) 27/81 (33.3)*° 136/258 (52.8) 58/119 (48.7)
Antibiotic prescriptions (%) 16/363 (4.4)* 131/1,296 (10.1) 42/597 (7.0)
Mothers, No. (%) 3/143 (2.1)* 38/519 (7.3) 11/239 (4.6)
Fathers, No. (%) 1/139 (0.7)* 29/519 (5.6) 5/239 (2.1)
Siblings, No. (%) 12/81 (14.8)*° 64/258 (24.8) 26/119 (21.8)
Lost working days by
mothers, mean ± SD
4.33 ± 2.16* 6.01 ± 2.57 3.46 ± 2.51*
Lost working days by fathers,
mean ± SD
1.39 ± 1.52* 3.36 ± 2.12 2.03 ± 2.57*
Lost school days by siblings,
mean ± SD
3.16 ± 4.01* 4.93 ± 3.91 3.39 ± 3.15*
SD, standard deviation. ^p < 0.05 vs influenza B; °p < 0.05 vs influenza B; *p < 0.05 vs A/H3N2; no other statistically significant differences. Lost parental working
days were due to caring for ill children and their personal illness.
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Table 4 Significant odds ratios (OR) and 95% confidence intervals (CI) of the associations between the influenza
subtypes and the characteristics of the study patients and their households
Influenza A/H1N1 vs influenza A/
H3N2 OR (95% CI)
Influenza A/H1N1 vs influenza
B OR (95% CI)
Influenza B vs influenza A/
H3N2 OR (95% CI)
Presence of fever
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.68 (0.41-0.99) 1.03 (0.66-1.79) 0.65 (0.39-0.94)
Presence of high-grade fever”
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.76 (0.55-0.97) 0.98 (0.62-1.55) 0.75 (0.53-0.96)
Upper respiratory tract infection
No 1 (reference) 1 (reference) 1 (reference)
Yes 1.34 (1.10-1.81) 0.86 (0.53-1.36) 1.31 (1.08-1.79)
Lower respiratory tract infection
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.60 (0.39-0.84) 1.19 (0.68-1.91) 0.69 (0.43-0.93)
Fever without source
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.64 (0.43-0.85) 1.12 (0.66-1.93) 0.61 (0.40-0.87)
Hospitalisation
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.57 (0.37-0.82) 0.61 (0.40-0.88) 0.84 (0.53-1.36)
Duration of hospitalisation (days)
< 7 days 1 (reference) 1 (reference) 1 (reference)
≥7 days 0.62 (0.40-0.90) 1.11 (0.85-1.42) 0.60 (0.39-0.85)
Absences from school (days)
< 7 days 1 (reference) 1 (reference) 1 (reference)
≥7 days 0.64 (0.43-0.91) 0.96 (0.61-1.74) 0.62 (0.42-0.98)
Antibiotic use
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.65 (0.44-0.93) 1.14 (0.66-1.98) 0.68 (0.47-0.94)
Antipyretic use
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.69 (0.40-0.91) 0.93 (0.54-1.91) 0.67 (0.39-0.96)
Aerosol therapy
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.65 (0.43-0.88) 1.18 (0.67-1.89) 0.62 (0.36-0.93)
Steroids
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.69 (0.39-0.94) 0.93 (0.58-1.67) 0.70 (0.49-0.95)
Household diseases similar to that of
the infected child
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.63 (0.41-0.92) 0.71 (0.42-0.94) 0.78 (0.50-0.98)
Additional medical visits among
households
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.68 (0.40-0.94) 0.74 (0.46-0.97) 0.79 (0.55-0.99)
Household antibiotic prescriptions
No 1 (reference) 1 (reference) 1 (reference)
Yes 0.65 (0.42-0.93) 0.87 (0.62-1.25) 0.91 (0.68-1.29)
Lost working days by mothers
< 3 days 1 (reference) 1 (reference) 1 (reference)
≥3 days 0.65 (0.34-0.89) 1.13 (0.54-1.92) 0.69 (0.38-0.96)
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Discussion
Most of the data collected during this study confirm
that influenza can cause substantial clinical and socio-
economic problems not only in children at risk of com-
plications but also in otherwise healthy children [1-5].
Our study population consisted only of otherwise
healthy children, the great majority of whom attended
the ERs with fever and respiratory tract infection, and a
considerable number were hospitalised and received
drug therapy, thus confirming that influenza leads to
high rates of hospitalisation and antipyretic and antibio-
tic prescriptions also among healthy pediatric subjects
[1,2].
Data showing that more than 70% of patients with
influenza received antibiotics are impressive in the light
of campaigns to reduce antibiotic usage in Europe, espe-
cially related to viral infections like influenza. The use
of rapid tests to confirm influenza diagnosis during epi-
demic periods in settings like ERs may be helpful for
reducing this inappropriate antibiotic abuse [26].
The findings also confirm that influenza can present
with fever without other accompanying symptoms, and
that its initial presentation may be gastroenteritis or feb-
rile seizures. Moreover, as previously reported [13], we
found that influenza B infection can present with unu-
sual manifestation, including myositis. However, the pre-
valence of acute otitis media (AOM) was significantly
lower than that reported in other studies of the compli-
cations of influenza [15,27] but similar to that previously
found by our group [6,26]. These differences can be
explained by the fact that we analysed signs and symp-
toms upon enrolment, whereas AOM can arise some
days after the beginning of the disease. Moreover, the
antibiotic prescription rate was very high in our popula-
tion, thus reducing the probability of AOM due to bac-
terial superinfection. Finally, our findings confirm that
influenza has a significant impact on households and
considerable socio-economic consequences among par-
ents and siblings [3,6].
The new study findings are those related to the impact
of the different viral types and subtypes, which show
that disease due to influenza A/H3N2 virus is signifi-
cantly more severe than that due to influenza A/H1N1
viral subtype and influenza B virus upon adjustment for
age and gender. In studies showing the greater clinical
importance of influenza A virus [18-20], this finding has
been mainly attributed to the fact that younger children
are at higher risk of severe influenza disease and that
influenza A infection is usually more common among
patients in the first five years of life. Our data suggest
that the viral subtypes themselves may play different
roles in conditioning the clinical and socio-economic
impact of influenza infection in children. Although our
patients infected by the A/H1N1 subtype were signifi-
cantly younger than those infected by the A/H3N2 sub-
type, the severity of the disease was less and quite
similar to that due to influenza B virus. Moreover, a
specific multivariate analysis upon adjustment for age
group and gender has been done showing that the
greater severity of A/H3N2 in this and other studies
[28-31] may be due to specific characteristics leading to
greater virulence.
This study was mainly focused on different types and
subtypes of seasonal influenza viruses, and no other
respiratory virus was evaluated. Further studies that
include possible differences and co-infections with
other respiratory viruses should be useful also for a
better understanding of influenza viruses’ pathogenesis.
Moreover, only the ER setting was evaluated and find-
ings in primary care could be partially different.
Finally, our data refer to the influenza seasons 2007-
2008 and 2008-2009, before the circulation of the pan-
demic A/H1N1 influenza virus. It is therefore possible
that these conclusions may not apply to the present
situation in which the new A/H1N1 subtype has com-
pletely replaced its predecessor. However, to the best
of our knowledge this is the largest study that evalu-
ates clinical as well as socioeconomic characteristics of
different types and subtypes of seasonal influenza
viruses in pediatrics.
Conclusions
Disease due to influenza A/H3N2 virus is significantly
more severe than that due to influenza A/H1N1 viral
subtype and influenza B virus, which indicates that the
characteristics of the different viral types and subtypes
Table 4 Significant odds ratios (OR) and 95% confidence intervals (CI) of the associations between the influenza sub-
types and the characteristics of the study patients and their households (Continued)
Lost working days by fathers
< 3 days 1 (reference) 1 (reference) 1 (reference)
≥3 days 0.58 (0.36-0.85) 0.87 (0.62-1.35) 0.65 (0.41-0.93)
Lost school days by siblings
< 3 days 1 (reference) 1 (reference) 1 (reference)
≥3 days 0.76 (0.54-0.97) 0.92 (0.70-1.38) 0.77 (0.58-0.98)
Odds ratios from multivariate logistic models, including terms for age and gender.
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should be adequately considered by health authorities
when planning preventive and therapeutic measures.
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